In order to achieve our long-term goals-supporting research to reduce new infections, improve health outcomes for those infected, and reduce disparities-we need to be at the cutting edge of scientific methods. Rigorous HIV science relies on optimal methods to address research questions. Investigators increasingly require timely, accessible, and specialized input to learn, select, and implement best practices in research design and measurement as well as data acquisition, management, and analysis. To meet these needs, the Methods Core provides expert methodological support through seminars, trainings, individual consultations, and peer review. By implementing the following aims, the Methods Core will foster innovative HIV science. The Methods Core collaborates with and supports CAPS scientists through all steps of the research process, from idea generation to the dissemination of final results. Reflecting the Center's long-term goals in the proposed funding period, the core will continue its strong record of support for CAPS scientists in a broad variety of research methods.

Agency
National Institute of Health (NIH)
Type
Center Core Grants (P30)
Project #
5P30MH062246-14
Application #
8717722
Study Section
Special Emphasis Panel (ZMH1)
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Rebeiro, Peter F; Gange, Stephen J; Horberg, Michael A et al. (2016) Geographic Variations in Retention in Care among HIV-Infected Adults in the United States. PLoS One 11:e0146119
Cesar, Carina; Koethe, John R; Giganti, Mark J et al. (2016) Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America. J Int AIDS Soc 19:20684
Rachlis, Beth; Karwa, Rakhi; Chema, Celia et al. (2016) Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Saf 39:959-76
Buchacz, Kate; Lau, Bryan; Jing, Yuezhou et al. (2016) Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. J Infect Dis 214:862-72
Klein, Marina B; Althoff, Keri N; Jing, Yuezhou et al. (2016) Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Clin Infect Dis 63:1160-1167
Koethe, John R; Jenkins, Cathy A; Lau, Bryan et al. (2016) Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr 73:197-204
Sauceda, John A; Wiebe, John S; Simoni, Jane M (2016) Childhood sexual abuse and depression in Latino men who have sex with men: Does resilience protect against nonadherence to antiretroviral therapy? J Health Psychol 21:1096-106
Vincent, Wilson; Gordon, Derrick M; Campbell, Christina et al. (2016) Adherence to Traditionally Masculine Norms and Condom-Related Beliefs: Emphasis on African American and Hispanic Men. Psychol Men Masc 17:42-53
Pettit, April C; Mendes, Adell; Jenkins, Cathy et al. (2016) Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment. J Acquir Immune Defic Syndr 72:572-8
Conroy, Amy A; McGrath, Nuala; van Rooyen, Heidi et al. (2016) Power and the association with relationship quality in South African couples: Implications for HIV/AIDS interventions. Soc Sci Med 153:1-11

Showing the most recent 10 out of 432 publications